Inid Research Lab, LLC

Inid Research Lab, LLC is a dietary development firm that operates under the consumer brand Continual-G®. The company is dedicated to advancing cellular health through scientifically-backed nutritional supplements. Headquartered in Fort Lauderdale, Florida, Inid Research Lab focuses on developing products that enhance the body's natural defense mechanisms.

Continual-G's primary product is a dietary supplement featuring Glyteine®, a proprietary form of gamma-glutamylcysteine (GGC). Glyteine® is designed to act as a direct precursor to glutathione, often referred to as the body's "master antioxidant." The supplement is clinically proven to rapidly increase cellular glutathione levels, which helps combat oxidative stress and supports overall cellular function. Continual-G® products are available in both powder and capsule forms and target market segments including general wellness, immune support, athletic performance and recovery, brain health, and skin health.

Since its launch in 2019, Continual-G® has been expanding its market presence, notably through increased brick-and-mortar retail partnerships across the United States. Recent expansions include placements in Greens Nutrition in Northern California (March 2026) and AlchePharma Naturals in Central California (February 2026). Rajan Shah serves as the President of Inid Research Lab LLC, overseeing the company's growth and strategic initiatives. The core Glyteine® ingredient was developed through extensive research by Professor Wallace Bridge and Dr. Martin Zarka at the University of New South Wales in Australia.